Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Chutes & Ladders—Former Legend CEO lands at K2

Chutes & Ladders—Former Legend CEO lands at K2

August 13, 2026Posted inBiotechnology

Just weeks after Legend Biotech announced the departure of its CEO, Ying Huang, K2 Therapeutics has announced that Wang will now lead the startup, which was founded in 2024 with a $50 million seed round from MPM BioImpact.

Post navigation

Previous Post
one-step-catalyst-synthesis-converts-carbon-dioxide-into-useful-methane One-step catalyst synthesis converts carbon dioxide into useful methane
Next Post
Phage contingency loci let viruses hedge against bacterial defenses phage-contingency-loci-let-viruses-hedge-against-bacterial-defenses

Recent Posts

  • Multi-lineage reprogramming and NOTCH-associated signaling remodeling characterize the aggressive biology of early-onset colorectal cancer
  • SYNGAP1 burden study will survey at least 125 U.S. caregivers
  • Research report: Simplifying the calibration of current measurement instruments with diamond quantum sensing technology
  • Cross-sectional study links multimorbidity, resilience, sleep and depressive symptoms in older adults
  • Machine learning reveals buckling prediction limits in cold-formed steel columns

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top